SECTOR:
Zenas BioPharma
FUND/VEHICLE:
Pivotal China
INVESTMENT DATE:
2021
GEOGRAPHY:
China
STATUS CURRENT/FORMER INVESTMENT:
Existing
WEBSITE:
Transforming the lives of patients with unmet medical needs by bringing best-in-class immune-based therapies to patients in need. Zenas BioPharma is a global biopharmaceutical company based in the USA and China committed to becoming a leader in the development and delivery of immune-based therapies for patients in need.
Zenas is rapidly advancing a deep portfolio of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases.